Market Newsdesk

SPARKS, Nev., April 14, 2021 /PRNewswire/ — Gen2 Technologies Inc. (the “Company”) (OTC: MNIZ) is pleased to announce that Colin Garrett Racing has chosen to participate in the rollout of the Iris Media Network, the latest high-profile entity to do so.

Management is pleased to welcome this newest member onboard, and looks to continue signing-up more content providers across various sports such as (not exclusive to) racing, soccer, football and basketball.

Pending the outcome of several material operational development leads, the company has chosen to delay its planned update call scheduled for this week. A new date and time will be announced when appropriate.

For further queries, please feel free to email the Company at: [email protected]

Gen2 Technologies Inc. (OTC PINK: MNIZ), aims to be a leader in the next phase of the digital age. Leveraging a portfolio of Intellectual Property (IP) covering camera, radio, distribution and blockchain technology, Gen2 Technologies will offer a superior user experience addressing a number of use cases across consumer, corporate and governmental end-markets. Our innovative first-mover Iris Media Network, employing our miniature body-worn Iris cameras, is positioned to disrupt the market for sports content and social media. Our IP focused on eKYC and best of breed aim / click / capture of still and video imagery directly into blockchain-enabled native format aims to address the high-potential of use cases such as digital COVID vaccination cards and superior NFT creation and management platforms.

The foregoing contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are intended to be covered by the safe harbor provisions of the federal securities laws. Forward-looking statements often contain words such as “will,” “anticipate,” “believe,” “plan,” “estimate,” “expect,” “intend,” “is targeting,” “may,” “should,” ”poised,” and other similar words or expressions. Forward-looking statements are made based upon management’s current expectations and beliefs and are not guarantees of future performance. Our actual business, financial condition or results of operations may differ materially from those suggested by forward-looking statements as a result of risks and uncertainties which include, among others, those described in any of our other filings with the SEC. In addition, such statements could be affected by risks and uncertainties related to: (i) commercialization of our newly-acquired helmet camera, (ii) continuing development and protection of our intellectual property, (iii) unexpected industry competition, (iv) the need to raise capital to meet business requirements, and (v) our ability to sell our products in order to generate revenues. Forward-Looking Statements are pertinent only as of the date on which they are made, and the company undertakes no obligation to update or revise any Forward-Looking Statements, whether as a result of new information, future developments or otherwise. Any future public statements or disclosures modifying any of the forward-looking statements contained in or accompanying this news release, will be deemed to supersede such statements in this news release. Information on Gen2 Technologies Inc.’s website, http://www.brkgen2.com does not constitute a part of this release.

Contact:
[email protected] 
brkgen2.com 
(440) 597-6150

 

View original content:http://www.prnewswire.com/news-releases/gen2-technologies-iris-media-network-signs-up-colin-garrett-racing-301268856.html

SOURCE Gen2 Technologies Inc.

SHANGHAI, April 14, 2021 /PRNewswire/ — Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, announced today that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Trodelvy^® (sacituzumab govitecan-hziy) to Gilead Sciences, Inc. (Nasdaq: GILD), a licensing partner of Everest Medicines, for use in adult patients with locally advanced or metastatic urothelial cancer (UC) who have previously received a platinum-containing chemotherapy and either a programmed death receptor-1 (PD-1) or a programmed death-ligand 1 (PD-L1) inhibitor.

The accelerated approval was based on data from the Phase 2, single-arm TROPHY study of 112 patients, which found that Trodelvy^®achieved a 27.7% overall response rate with a 7.2-month median duration of response. Continued approval for this indication is contingent upon verification and description of clinical benefit in a confirmatory trial.

Under a licensing agreement with Gilead Sciences, Inc., Everest Medicines has exclusive rights to develop, register, and commercialize sacituzumab govitecan-hziy for all cancer indications in Greater China, South Korea, and certain Southeast Asian countries.

“This accelerated approval of Trodelvy^® for metastatic UC, a devastating disease with previously limited treatment options, marks an exciting milestone for patients in the U.S. and around the world,” said Kerry Blanchard, MD, PhD, CEO of Everest Medicines. “We applaud Gilead Sciences for its extensive and encouraging datasets as well as its comprehensive and ongoing global regulatory strategy in this important disease area. At Everest Medicines, we look forward to continuing to advance late-stage development of Trodelvy^® for patients in Greater China and other parts of Asia as part of the collective effort to make this innovative treatment available to patients around the world.”

In December 2020, the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) approved a Clinical Trial Application (CTA) for sacituzumab govitecan-hziy for the treatment of patients with metastatic UC.  Everest Medicines plans to enroll patients in China as part of global Phase 3 TROPiCS-04 confirmatory trial, which is underway and is also intended to support global registrations.

About Urothelial Cancer

Urothelial cancer is a type of cancer that begins in urothelial cells that line the urethra, bladder, ureters, renal pelvis, and some other organs that make up the urinary system. According to Frost & Sullivan, in 2019, the incidence of urothelial cancer reached 76,400 in China.  

About
Trodelvy^® (
sacituzumab
govitecan-hziy)

Trodelvy^® (sacituzumab govitecan-hziy) is a first-in-class, antibody-drug conjugate (ADC) directed at TROP-2, a membrane antigen that is over-expressed in many common epithelial cancers.

In addition to its indication in locally advanced or metastatic UC, Trodelvy^® is approved in the U.S. to treat adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies, at least one of them for metastatic disease.

About Everest Medicines

Everest Medicines is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other Asian markets. The management team of Everest Medicines has deep expertise and an extensive track record of high-quality clinical development, regulatory affairs, CMC, business development and operations both in China and with leading global pharmaceutical companies. Everest Medicines has built a portfolio of eight potentially global first-in-class or best-in-class molecules, many of which are in late stage clinical development. The Company’s therapeutic areas of interest include oncology, autoimmune disorders, cardio-renal diseases and infectious diseases. For more information, please visit its website at www.everestmedicines.com. 

View original content:http://www.prnewswire.com/news-releases/everest-medicines-announces-that-the-us-fda-has-granted-licensing-partner-gilead-sciences-inc-accelerated-approval-of-trodelvy-for-the-treatment-of-metastatic-urothelial-cancer-301268852.html

SOURCE Everest Medicines

NEW YORK, April 14, 2021 /PRNewswire/ — Aquavit Holdings LLC announced today that it acquired an exclusive license to register, market and commercialize a botulinum toxin (DTX-021) in the United States and Canada.

For several years, Aquavit has been investing in its proprietary delivery technologies and related intellectual property for botulinum toxin and recently proved its efficacy and safety through a clinical study. It also compared and evaluated optimal dosing with three FDA approved botulinum toxins with varying injection depths and widths.

According to a published article by American Society for Dermatologic Surgery (ASDS), the licensed asset DTX-021 showed equivalency on glabellar lines and improvement on periorbital rhytids compared to onabotulinumtoxinA (BOTOX®) in a multicenter, double-blind, randomized, parallel, active-controlled phase III clinical trial. There were no adverse events.

The manufacturing partner is Huons Bio Pharma (“Huons”),  a spin-off from the publicly traded South Korean corporation Huons Global Co. Ltd. [KOSDAQ: 084110]

With this deal, Huons will receive sizable milestone payments and royalties in addition to an upfront payment, and become the exclusive supplier of Aquavit’s botulinum toxin. Aquavit plans to initiate the registration process by filing an IND with the FDA shortly.

“We are thrilled to partner with Huons for this venture. Together, we will introduce the most innovative botulinum toxin product, and uplift and modernize the treatment paradigm,” said Sobin Chang, CEO of Aquavit.

According to The Aesthetic Society and the Global Market Insights, botulinum toxin has been the #1 non-surgical aesthetic procedure since 1999 and is still growing rapidly. The North America botulinum toxin market alone was valued at $3.19B in 2019. With a projected CAGR of 7-9%, the global botulinum toxin market in 2026 is expected to be $8.9B

“Aquavit’s proven track record of developing and launching a global brand such as AQUAGOLD®, combined with its knowledge of the botulinum toxin market, and its network of over 20,000 physicians worldwide who use botulinum toxin products, can make a significant impact in the fast growing market with only 4 companies with an FDA approval today,” said Marc Toulemonde, Aquavit’s board member and an industry leader in top beauty and aesthetic brands.

About Aquavit
Aquavit is a high-tech pharmaceutical company that provides a comprehensive range of innovative pharmaceutical, biotech and medical device technologies. Aquavit focuses on personalized medicine to improve patients’ health, maximize the efficiency of our medical community, and support the pharmacoeconomics of payers.

About Huons
Huons Bio Pharma is a recent spin-off of the publicly traded South Korean corporation Huons Global Co. Ltd. [KOSDAQ: 084110]. Huons Global focuses “on supporting the growth of its affiliates’ original businesses, managing each company’s business portfolio and enhancing brand value”. The company was founded in 1965 and is headquartered in Seongnam-si, South Korea. Huons Bio Pharma will promote the group’s biopharmaceutical business, such as botulinum toxin, and develop new drugs.

 

View original content:http://www.prnewswire.com/news-releases/aquavit-to-introduce-a-new-botulinum-toxin-dtx-021-301268845.html

SOURCE Aquavit Pharmaceuticals, Inc.

IRVING, Texas, April 14, 2021 /PRNewswire/ — EnviroFlight, a wholly owned division of Darling Ingredients Inc. (NYSE: DAR), announced the development of a new R&D and Corporate Center in Apex, North Carolina. This area of North Carolina has a strong focus on agriculture technology and agriculture research, and is an ideal location to meet the needs of a growing regenerative agriculture business conducting highly technical research on black soldier flies and their larvae. Groundbreaking on the new facility starts April 2021, and EnviroFlight expects to be in the facility in early 2022.

This new R&D facility will allow for further emphasis to be placed on target research areas, including expanding the knowledge base for alternative uses of black soldier fly larvae (BSFL) in animal health, animal nutrition, cosmetics, and other product development. EnviroFlight is currently the only company to produce BSFL on a commercial scale in the United States and has its first manufacturing plant located in Maysville, Kentucky. This innovative and responsible approach has considerable potential within the sizable global animal feed industry as it will provide an environmentally friendly, sustainable source of high-value nutrients.

Liz Koutsos, President of EnviroFlight, said, “Research and development is a core focus area for EnviroFlight, with our research team and dedicated engineers focused on all aspects of insect biology and production including genetics, immunology, animal nutrition, and innovative engineering solutions.  As part of our growth plan, we are excited to invest in a new R&D and Corporate Center in Apex NC, and join the robust Triangle Region AgTech community. This new facility will allow us to continue to develop technology that leverages the potential of this amazing insect and facilitate our growth in the alternative protein industry.”

About EnviroFlight
EnviroFlight is a leader in sustainable insect ingredients designed for animal and plant nutrition, aiming to drive transformative change in the global food supply. It is the leading developer of proprietary technologies which enable the rearing of black soldier fly larvae in a scalable manner. EnviroFlight’s mission is to use regionally available, low-value materials, emphasizing production of nutrients in a socially responsible way and reducing the environmental and financial costs to our food supply.  For more detail about EnviroFlight, visit www.EnviroFlight.net.

About Darling
Darling Ingredients Inc. (NYSE: DAR) is one of the world’s leading producers of organic ingredients, producing a wide array of sustainable protein and fat products while being one of the largest producers of renewable clean energy. With operations on five continents, Darling collects waste streams from the agri-food industry, repurposing into specialty ingredients, such as hydrolyzed collagen, edible and feed-grade fats, animal proteins and meals, plasma, pet food ingredients, fuel feedstocks, and green bioenergy. The Company sells its products around the globe and works to strengthen our promise for a better tomorrow, creating product applications for health, nutrients and bioenergy while optimizing our services to the food chain. Darling is a 50% joint partner in Diamond Green Diesel (DGD), North America’s largest renewable diesel manufacturer, currently producing approximately 290 million gallons of renewable diesel annually which products reduce Green House Gas (GHG) emissions by up to 85% compared to fossil fuels. For additional information, visit the Company’s website at http://www.darlingii.com. For more information on Darling’s ESG efforts, visit http://www.darlingii.com/csr.

Safe Harbor Statement
Some of the statements made in this press release are forward-looking statements. These forward-looking statements are based upon our current expectations and projections about future events and generally relate to our plans, objectives and expectations for the development of our business. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.

For more information:

Carrie Kuball, VP Sales and Marketing, Email: [email protected] Tel: +651.503.2983

Investor Relations:

Jim Stark, VP Investor Relations, Email: [email protected]  Tel: +972-281-4823

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/darling-ingredients-enviroflight-brand-announces-new-rd-and-corporate-center-to-be-based-in-north-carolina-301268779.html

SOURCE Darling Ingredients Inc.

DALLAS, April 14, 2021 /PRNewswire/ —

What’s the news? 

Today, AT&T announced it will invest $2 billion over the next 3 years to help address the digital divide. 

This renewed commitment to the communities we serve combines AT&T’s low-cost broadband service offerings with community investment. And it builds on the company’s contribution of $1 billion over the last 3 years toward helping the nation’s most vulnerable communities.

We’re dedicated to doing our part to bring affordability, educational resources, and economic opportunity to the millions of Americans who don’t have broadband connectivity today.

“We believe that broadband connectivity is essential for all Americans,” said John Stankey, CEO, AT&T. “Our broadband networks rose to the challenge of the pandemic in part due to policies that promoted private sector investment in multiple technologies and networks. AT&T is investing in and expanding the reach of our broadband networks while also advocating for effective and sustainable public policies that help close this country’s digital divide.”

How will we do this?

Expanding affordable broadband through AT&T’s low-cost offers and the Emergency Broadband Benefit program administered by the FCC

• Education Offers: We continue to offer discounted wireless solutions to more than 135,000 public and private K-12 schools, colleges, and universities. These offers help keep students and teachers connected in a 1:1 learning model to assist in transforming education beyond when schools reopen. High-speed internet should enable new learning opportunities, not be the barrier to them. That’s why we’ve stepped up our support over the last year to address education inequality for the almost 17 million students, predominately children of color in low-income and rural households, who don’t have internet connectivity.
• Access from AT&T: Introduced 5 years ago, this AT&T-funded program makes the internet more affordable for customers by providing qualifying households with wireline internet service at $10 or less per month. This voluntary offer from AT&T has no contract or installation fee. Plus, it includes in-home Wi-Fi at no additional cost. We are continuing to waive data overages for these customers, and we’re keeping the expanded eligibility to qualifying households and those participating in the National School Lunch Program and Head Start. Hundreds of thousands of Americans enjoy Access from AT&T, and we aim to build upon this voluntary program, partnering with government policymakers to ensure sustainable funding to keep broadband options affordable for qualifying households.
• Emergency Broadband Benefit (EBB): In another move to make the internet more affordable for more people, eligible customers will be able to temporarily reduce their monthly broadband costs by taking advantage of the Federal Emergency Broadband Benefit (EBB). This government program administered by the FCC will allow more than 30 million eligible¹ households to receive an additional subsidy of up to $50 a month. Those on Tribal lands are eligible for up to $75 per month. The monthly cost of broadband – after applying the Emergency Broadband Benefit – can fall to as low as $0 a month.²

The EBB can be applied to eligible home internet services like Access from AT&T or AT&T Internet, available within our 21-state wireline footprint. Or it can be applied toward eligible postpaid or prepaid wireless plans at AT&T, AT&T PREPAID and Cricket Wireless, which are available in all 50 states.

Once customers verify that they are eligible, we’ll apply the benefit to their service until the EBB ends. The uniform program start date is pending an FCC announcement.

“We tip our hat to Acting FCC Chairwoman Jessica Rosenworcel for her leadership in making the Emergency Broadband Benefit available to more than 30 million households,” Stankey said. “The EBB is a great first step in addressing affordability in the short term. We continue to encourage Congress to work on more permanent solutions with sustainable funding so that all Americans can have access to affordable broadband.”

Last week, AT&T joined nearly 50 advocacy organizations, companies, and non-profit groups setting out the guiding principles for Congress and the Biden Administration as it debates the specifics for the American Jobs Plan. We urged policy makers to enact sustainable, effective broadband policies that have proven to build the most resilient broadband networks, create jobs and empower opportunities for all Americans.

“The COVID-19 pandemic has laid bare the broadband challenges we have been fighting to resolve for years,” said Marc Morial, President & CEO, National Urban League. “We applaud AT&T’s recent efforts to ensure that all people – and especially historically unserved and underserved communities — can access affordable, reliable broadband internet.”

Will Townsend, senior analyst with Moor Insights & Strategy, added: “The digital divide in America is real and the challenges are being magnified during the pandemic. Many have to scramble to find Wi-Fi hotspots to support critical activities such as telemedicine sessions and distance learning.  I applaud AT&T’s efforts to bridge the connectivity gap with incremental investments and subscriber subsidies, as well as no-cost educational content through its WarnerMedia division.”  

Linda Ng, National President, OCA-Asian Pacific American Advocates, said: “As we work to remedy existing gaps in internet access and overcome the challenges associated with connecting every single American to broadband service, we celebrate the efforts of AT&T and others working hard to help close the digital divide. This kind of sustained industry engagement will be indispensable for getting families, students, educators, and others in communities with the most urgent need online.”

Introducing AT&T Connected Learning

According to a recent Morning Consult survey, more than 70% of parents and teachers think the traditional classroom learning environment will rely more heavily on technology after the pandemic. Additionally, 80% say their kids would be more interested in learning tools that include popular entertainment.

AT&T Connected Learning is our multi-year commitment to help stem the tide of learning loss, narrow the homework gap, and create compelling educational content. The initiative builds on our previous investments and long-standing commitment to education. It includes multiple solutions to connect today’s learners with the skills, resources, and opportunities for success in school and in life.

Together with WarnerMedia, we’re developing a digital learning platform that will deliver high quality educational content and curriculum everywhere today’s connected students learn – in the classroom, at home, and in the community. This digital resource will provide:

• Exclusive educational content from WarnerMedia properties and talent.
• Learning tools from leading education groups to help students and families navigate distance learning and improve academic success. The platform will also provide resources to support socio-emotional learning and critical thinking skills.

In collaboration with our employees and local organizations, we’re launching  20 AT&T Connected Learning Centers in 2021. These Connected Learning Centers will be in traditionally underserved neighborhoods where residents face barriers to connectivity. 

• To facilitate digital learning at the centers, we’ll provide high-speed AT&T Fiber internet, Wi-Fi and ensure the centers have the resources for devices like laptops and tablets. In addition, the centers will have access to WarnerMedia content. We’ll also provide access to virtual learning tools from collaborators like Khan Academy.
• Students will have opportunities to be mentored and tutored through our employee-driven AT&T Believes volunteerism initiative. The resources that will be available at the centers will allow students to complete assignments and access digital learning tools content with ease. These centers will help reach more students from historically under-resourced communities and provide them with the access, tools, and mentoring they need to succeed. 

Together with Public Library Association (PLA), a division of the American Library Association, we will offer a specially curated collection of digital literacy courses to help parents and families build the skills and confidence they need to help their child navigate distance learning and participate effectively and safely in today’s digital world. Courses will be available virtually for everyone and offered in-person at our Connected Learning Centers and public libraries and as part of PLA’s nationwide digital literacy initiative.

*About AT&T Communications

We help family, friends and neighbors connect in meaningful ways every day. From the first phone call 140+ years ago to mobile video streaming, we @ATT innovate to improve lives. AT&T Communications is part of AT&T Inc. (NYSE: T). For more information, please visit us at att.com.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/att-makes-2-billion-3-year-commitment-to-help-bridge-the-digital-divide-301268838.html

SOURCE AT&T Communications